Webster R., Bean W.J., Gorman O. et al. Evolution and ecology of influenza A viruses // Microbiol. Rev. — 1993. — Vol. 56, № 2. — P. 152–179.
Webster R. Influenza: An Emerging Disease // Emerging Infectious Diseases. — 1998. - Vol.4, № 3. — P. 416–419.
Weinstein R.A. Nosocominal Infection Update // Emerging Infectious Diseases. — 1998. - Vol.4, № 1. — P. 22–45.
Werner G.T., Jentzsch U., Metzger E. et al. // Arch. Virol. — 1968. — Vol. 64, № 3. — P. 247–256.
Wiener S.L. Strategies of Biowaffarae Defense // Military Medicine. — 1987. — Vol. 152, № 1. — P. 25–28.
Wilson M. Travel and the Emergence of Infectious Diseases // Emerging Infectious Diseases. — 1995. - Vol.1, № 2. — P. 12–20.
Wilson A., Symons J., McDowell T. et. al. Effects of polymorphism in the tumor necrosis factor alpha promoter on transcriptional activation // Proc. Natl. Acad. Sci. USA. — 1997. — Vol. 94, № 10. — P. 3195–3199.
Whitnack E. Sepsis // Mechanisms of microbial disease. — Baltimore, 1993.
Xuminer D., Rosenfeld G.B., Pitlik S.D. AIDS in pre-AIDS era // Rev. Infect. Dis.- 1987.- V.9.- P.1102—.1109.
Yoshimi M., Fumiaki I., Toshiaki T. et al. Novel Plasmid-mediated-lactamase from Escherichia coli That Inactivates Oximini-cephalosporins // Antimicrob. Agents and Chemoter. — 1988. — Vol. 32, № 8. — P. 1243–1246.
Zeng L., Kurane I., Okamoto Y. et al. Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones // J.Virol. — 1996. — Vol. 70, № 12. — P. 3108–3117.
Zimmerman P., Bucklerwhite A., Alkhatib G. et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5-studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk // Mol. Med. — 1997. — Vol. 3, № 1. — P. 23–36.